GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Terumo Corp (OTCPK:TRUMY) » Definitions » Short Percentage of Float

TRUMY (Terumo) Short Percentage of Float


View and export this data going back to 2008. Start your Free Trial

What is Terumo Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of Terumo's Short Percentage of Float

For the Medical Instruments & Supplies subindustry, Terumo's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Terumo's Short Percentage of Float Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Terumo's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where Terumo's Short Percentage of Float falls into.


;
;

Terumo Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Terumo Corp (OTCPK:TRUMY) » Definitions » Short Percentage of Float
Comparable Companies
TSE:7741 TSE:7747 TSE:8086 TSE:3360 TSE:7716 TSE:3046 TSE:7817 TSE:7730 TSE:3593 TSE:7780 ISRG XPAR:EL BDX XSWX:ALC RMD OCSE:COLO B XSWX:STMN XPAR:DIM BAX COO
Traded in Other Exchanges
TRUMF:USA 4543:Japan TUO0:Germany
Address
2-44-1 Hatagaya, Shibuya-ku, Tokyo, JPN, 151-0072
Website
https://www.terumo.com
Started as a clinical thermometer producer in Japan in 1921, Terumo is a comprehensive medical device player with a diversified global revenue. Its product portfolio includes prefilled syringes, insulin patch pumps, neurovascular or cardiac vascular interventional devices, and blood processing systems. As of 2024, the cardiac and vascular business is the largest segment, contributing over 60% of its total revenue. Geographically, North America is the largest region, with 36% of Terumo's revenue.